MNPR Stock Summary and Trading Ideas (Monopar Therapeutics | NASDAQ:MNPR)

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. The group radiopharmaceutical programs consist of Phase 1-stage MNPR-101-Zr for imaging cancers, and Phase 1a-stage MNPR-101-Lu and late preclinical-stage MNPR-101-Ac for the treatment of cancers that express urokinase plasminogen activator receptor (uPAR). It build drug development pipeline through both in-house efforts and licensing of late preclinical- and clinical-stage therapeutics. The Company operates as a single reportable segment, focusing on the development of clinical and preclinical product candidates.

Monopar Therapeutics trades on the NASDAQ stock market under the symbol MNPR.

As of June 12, 2026, MNPR stock price climbed to $59.77 with 154,220 million shares trading.

MNPR has a beta of 0.89, meaning it tends to be less sensitive to market movements. MNPR has a correlation of 0.02 to the broad based SPY ETF.

MNPR has a market cap of $400.40 million. This is considered a Small Cap stock.

In the last 3 years, MNPR traded as high as $105.00 and as low as $1.37.

The top ETF exchange traded funds that MNPR belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.

MNPR has outperformed the market in the last year with a return of +76.7%, while the SPY ETF gained +24.1%. However, in the most recent history, MNPR shares have underperformed the stock market with its stock returning +3.8% in the last 3 month period and -8.1% for the last 2 week period, while SPY has returned +11.6% and -1.9%, respectively.

MNPR support price is $55.77 and resistance is $62.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MNPR shares will trade within this expected range on the day.